CD45-positive tumor infiltrating lymphocytes in early-stage hormone-positive, HER2-negative (ER+/HER2-) breast cancer: Correlation with proliferation and prognostic signature scores. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results